Lynx1 Capital Management LP

Holdings History for Allogene Therapeutics, Inc. - Common Stock (ALLO)

Symbol: ALLO on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock
Latest Disclosed Ownership: 10.9M shares
Security Ownership: 5.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Lynx1 Capital Management LP ownership in Allogene Therapeutics, Inc. Common Stock (ALLO)

2025-02-14 - Lynx1 Capital Management LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 10.9M shares of Allogene Therapeutics, Inc. Common Stock (ALLO). This represents 5.2% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Lynx1 Capital Management LP	5.2%		$20.6M	10.9M			$1.89	13G	12/31/2024	14 Feb 2025 09:02:11

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	8.68%	+3.73%	$23.2M	10.9M	+4,672,349	+75.3%	$2.13	Q4 2024
9/30/2024	6.15%	+3.94%	$17.4M	6.2M	+3,974,079	+178%	$2.80	Q3 2024
6/30/2024	1.88%	+1.34%	$5.19M	2.23M	+2,228,295	NEW	$2.33	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.